These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20493293)

  • 1. A label-free electrochemical test for DNA-binding activities of tumor suppressor protein p53 using immunoprecipitation at magnetic beads.
    Nemcová K; Havran L; Sebest P; Brázdová M; Pivonková H; Fojta M
    Anal Chim Acta; 2010 Jun; 668(2):166-70. PubMed ID: 20493293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the level of DNA modification with cisplatin by catalytic hydrogen evolution at mercury-based electrodes.
    Horáková P; Tesnohlídková L; Havran L; Vidláková P; Pivonková H; Fojta M
    Anal Chem; 2010 Apr; 82(7):2969-76. PubMed ID: 20187631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor protein p53 binds preferentially to supercoiled DNA.
    Palecek E; Vlk D; Stanková V; Brázda V; Vojtesek B; Hupp TR; Schaper A; Jovin TM
    Oncogene; 1997 Oct; 15(18):2201-9. PubMed ID: 9393978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical sensing of tumor suppressor protein p53-deoxyribonucleic acid complex stability at an electrified interface.
    Paleček E; Cernocká H; Ostatná V; Navrátilová L; Brázdová M
    Anal Chim Acta; 2014 May; 828():1-8. PubMed ID: 24845809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical detection of DNA binding by tumor suppressor p53 protein using osmium-labeled oligonucleotide probes and catalytic hydrogen evolution at the mercury electrode.
    Němcová K; Sebest P; Havran L; Orság P; Fojta M; Pivoňková H
    Anal Bioanal Chem; 2014 Sep; 406(24):5843-52. PubMed ID: 25056872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mutant p53 using field-effect transistor biosensor.
    Han SH; Kim SK; Park K; Yi SY; Park HJ; Lyu HK; Kim M; Chung BH
    Anal Chim Acta; 2010 Apr; 665(1):79-83. PubMed ID: 20381694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of p53 sequence-specific binding by DNA supercoiling.
    Palecek E; Brázda V; Jagelská E; Pecinka P; Karlovská L; Brázdová M
    Oncogene; 2004 Mar; 23(12):2119-27. PubMed ID: 14755248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
    Wolkowicz R; Elkind NB; Ronen D; Rotter V
    Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting.
    Liu Y; Asch H; Kulesz-Martin MF
    Cancer Res; 2001 Jul; 61(14):5402-6. PubMed ID: 11454683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for target sequences by p53 protein is influenced by DNA length.
    Brázda V; Jagelská EB; Fojta M; Palecek E
    Biochem Biophys Res Commun; 2006 Mar; 341(2):470-7. PubMed ID: 16426567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads.
    Centi S; Tombelli S; Minunni M; Mascini M
    Anal Chem; 2007 Feb; 79(4):1466-73. PubMed ID: 17297945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies.
    Brázda V; Paleĉek J; Pospísilová S; Vojtêsek B; Paleĉek E
    Biochem Biophys Res Commun; 2000 Jan; 267(3):934-9. PubMed ID: 10673394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picomolar level profiling of the methylation status of the p53 tumor suppressor gene by a label-free electrochemical biosensor.
    Wang P; Wu H; Dai Z; Zou X
    Chem Commun (Camb); 2012 Nov; 48(87):10754-6. PubMed ID: 23010984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of an electrochemical DNA sensor array via potential-assisted "click" chemistry.
    Cañete SJ; Lai RY
    Chem Commun (Camb); 2010 Jun; 46(22):3941-3. PubMed ID: 20419182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical probe for the monitoring of DNA-protein interactions.
    Meunier-Prest R; Bouyon A; Rampazzi E; Raveau S; Andreoletti P; Cherkaoui-Malki M
    Biosens Bioelectron; 2010 Aug; 25(12):2598-602. PubMed ID: 20447818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.